3rd Merck Singulair Suit Stayed For Ruling In 1st Case
A Merck & Co. unit and Teva Pharmaceuticals USA Inc. have lodged a consent decree in Merck's third suit over a patent for blockbuster allergy and asthma drug Singulair, agreeing to...To view the full article, register now.
Already a subscriber? Click here to view full article